BIOM-13. DNA METHYLATION MARKS GLUCOCORTICOID PATHWAY RESPONSE IN DEXAMETHASONE-TREATED BRAIN TUMOR PATIENTS

Dexamethasone (DEX) is routinely prescribed in brain tumor patients to limit vasogenic edema but may also exacerbate immunosuppression and adversely affect survival. The wide spectrum of dosing and individual variation in glucocorticoid (GC) response makes it difficult to assess the impact of DEX ex...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Wiencke, John, Molinaro, Annette, Warrier, Gayathri, Rice, Terri, Clarke, Jennifer, Taylor, Jennie, Wrensch, Margaret, Tamaki, Stanley, Lee, JiYoon, Hansen, Helen, McCoy, Lucie, Bracci, Paige, Salas, Lucas, Koestler, Devin, Christensen, Brock, Kelsey, Karl
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Biomarkers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650309/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados